NUS - NU SKIN ENTERPRISES, INC.
7.62
0.060 0.787%
Share volume: 814,721
Last Updated: 03-04-2026
Wholesale/Wholesale – Drugs & Drug Proprietaries:
-0.08%
PREVIOUS CLOSE
CHG
CHG%
$7.56
0.06
0.01%
View ratios
| Fiscal Date | 03-31-2024 | 06-30-2024 | 09-30-2024 | 12-31-2024 | 03-31-2025 | 06-30-2025 | 09-30-2025 | 12-31-2025 | |
|---|---|---|---|---|---|---|---|---|---|
| Fiscal Quarter | Q1 2024 | Q2 2024 | Q3 2024 | Q4 2024 | Q1 2025 | Q2 2025 | Q3 2025 | Q4 2025 | |
| Report Date | 05-09-2024 | 08-09-2024 | 11-08-2024 | 02-14-2025 | 05-09-2025 | 08-07-2025 | 11-06-2025 | 02-13-2026 | |
| Assets | |||||||||
| Total Assets | 1.742 B | 1.586 B | 1.583 B | 1.469 B | 1.391 B | 1.444 B | 1.424 B | 1.405 B | |
| Current Assets | 647.260 M | 654.406 M | 653.371 M | 538.599 M | 524.857 M | 571.553 M | 548.143 M | 547.698 M | |
| Inventories | 265.100 M | 243.994 M | 247.789 M | 190.242 M | 188.776 M | 180.377 M | 178.533 M | 178.643 M | |
| Other Current Assets | 93.913 M | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Short Term Investments | 93.913 M | 8.671 M | 10.077 M | 11.111 M | 9.781 M | 1.211 M | 1.210 M | 1.211 M | |
| Total Receivables | 67.041 M | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Current Cash | 221.206 M | 224.250 M | 227.751 M | 186.883 M | 203.770 M | 264.159 M | 251.787 M | 238.630 M | |
| Total Non-current Assets | 1.095 B | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Property Plant Equipment | 422.818 M | 411.918 M | 410.673 M | 379.595 M | 380.067 M | 374.207 M | 375.280 M | 377.168 M | |
| Other Assets | 246.044 M | 519.648 M | 518.851 M | 550.720 M | 486.487 M | 497.933 M | 500.983 M | 480.447 M | |
| Intangible Assets | 101.933 M | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Goodwill | 230.768 M | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Liabilities and shareholders’ equity | |||||||||
| Total Liabilities and shareholders’ equity | 1.742 B | 1.586 B | 1.583 B | 1.469 B | 1.391 B | 1.444 B | 1.424 B | 1.405 B | |
| Total liabilities | 931.709 M | 899.808 M | 876.020 M | 817.459 M | 637.442 M | 655.939 M | 624.611 M | 600.073 M | |
| Total current liabilities | 309.305 M | 308.593 M | 339.351 M | 296.607 M | 260.300 M | 283.906 M | 254.437 M | 263.734 M | |
| Accounts Payable | 32.237 M | 36.305 M | 32.736 M | 34.880 M | 33.590 M | 28.734 M | 28.523 M | 26.183 M | |
| Other liabilities | 95.023 M | 162.888 M | 163.199 M | 155.914 M | 158.385 M | 158.133 M | 161.130 M | 132.152 M | |
| Current long term debt | 30.000 M | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Long term debt | 453.183 M | 428.327 M | 373.470 M | 363.613 M | 218.757 M | 213.900 M | 209.044 M | 204.187 M | |
| Other liabilities | 95.023 M | 162.888 M | 163.199 M | 155.914 M | 158.385 M | 158.133 M | 161.130 M | 132.152 M | |
| Minority interest | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Total Shareholder equity | 810.206 M | 686.164 M | 706.875 M | 651.455 M | 753.969 M | 787.754 M | 799.795 M | 805.240 M | |
| Common stock | 49.538 M | 621.531 M | 624.756 M | 627.878 M | 623.568 M | 627.606 M | 633.252 M | 636.085 M | |
| Retained earnings | 1.867 B | 1.746 B | 1.751 B | 1.712 B | 1.816 B | 1.835 B | 1.849 B | 1.860 B |